Is Adaptimmune Therapeutics plc (ADAP) a Buy, Sell, or Hold?
NASDAQ : ADAP
Adaptimmune Therapeutics plc — Institutional Ownership
$0.0485 USD
$0.0 (-3.0%)
- Volume
- 1.68M
- Average Volume
- 110.64M
- Market Capitalization
- $75.16M
- P/E Ratio
- -0.16
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $0.86
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.52
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-02-17 | LONG FOCUS CAPITAL MANAGEMENT, LLC | - | 0.00% |
| 2025-11-14 | Two Seas Capital LP | - | 0.00% |
| 2025-08-19 | Scott D. Sandell | 4.0 | 0.00% |
| 2025-08-19 | Anthony A. Florence, Jr. | 4.0 | 0.00% |
| 2025-08-19 | Forest Baskett | 4.0 | 0.00% |
| 2025-08-19 | NEA 16 GP, LLC | 4.0 | 0.00% |
| 2025-08-19 | NEA Partners 16, L.P. | 4.0 | 0.00% |
| 2025-08-19 | New Enterprise Associates 16, L.P. | 4.0 | 0.00% |
| 2025-08-19 | NEA 14 GP, LTD | 4.0 | 0.00% |
| 2025-08-19 | NEA Partners 14, L.P. | 4.0 | 0.00% |
| 2025-08-19 | New Enterprise Associates 14, L.P. | 4.0 | 0.00% |
| 2025-08-19 | Patrick J. Kerins | 4.0 | 0.00% |
| 2025-08-19 | EcoR1 Capital, LLC | 66M | 4.20% |
| 2025-08-19 | Mohamad H. Makhzoumi | 4.0 | 0.00% |
| 2025-08-13 | Two Seas Capital LP | 135.48M | 8.50% |
| 2025-05-15 | Two Seas Capital LP | 123.18M | 8.00% |
| 2025-02-14 | Two Seas Capital LP | 89.01M | 5.80% |
| 2025-02-12 | BAILLIE GIFFORD & CO | 70.91M | 4.60% |
| 2025-02-11 | LONG FOCUS CAPITAL MANAGEMENT, LLC | 20.49M | 8.00% |
| 2025-01-08 | Matrix Capital Management Company LP | - | 0.00% |
| 2024-01-30 | EcoR1 Capital, LLC | 113.42M | 11.00% |
| 2024-01-30 | EcoR1 Capital Fund Qualified, L.P. | 106.99M | 11.00% |
| 2024-01-30 | Oleg Nodelman | 113.42M | 11.00% |
| 2023-11-08 | S | 6.58M | 2.90% |
| 2023-11-08 | S | 6.58M | 2.90% |
| 2023-11-08 | S | 4.73M | 2.10% |
| 2023-11-08 | S | 11.31M | 5.00% |
| 2023-11-08 | S | 4.73M | 2.10% |
| 2022-05-09 | PFM Health Sciences, LP | 6.0 | 5.80% |
| 2022-01-18 | Baillie Gifford & Co (Scottish partnership) | 82.54M | 11.00% |
| 2021-02-16 | Julian C. Baker | 58.99M | 6.40% |
| 2021-02-16 | Baker Bros. Advisors LP | 58.99M | 6.40% |
| 2021-02-16 | 95-1411037 | 13.0 | 5.20% |
| 2021-02-16 | Felix J. Baker | 58.99M | 6.40% |
| 2021-02-16 | Baker Bros. Advisors (GP) LLC | 58.99M | 6.40% |
| 2021-01-28 | Baillie Gifford & Co (Scottish partnership) | 62.15M | 11.00% |
| 2020-02-14 | David E. Goel | 168M | 26.65% |
| 2020-02-14 | Matrix Capital Management Company LP | 168M | 26.65% |
| 2020-02-14 | Capital World Investors ** | 40.76M | 6.40% |
| 2019-02-14 | Nicholas John Cross | 29.04M | 4.62% |
| 2019-01-10 | Matrix Capital Management Company LP | 162.89M | 26.00% |
| 2019-01-10 | David E. Goel | 162.89M | 26.00% |
| 2018-03-29 | OrbiMed Advisors LLC | 30.61M | 5.44% |
| 2018-03-29 | OrbiMed Capital GP V LLC | 30.61M | 5.44% |
| 2018-02-14 | David E. Goel | 73.28M | 13.00% |
| 2018-02-14 | Matrix Capital Management Company LP | 73.28M | 13.00% |
| 2018-02-13 | FMR LLC | 27.79M | 4.94% |
| 2018-02-13 | Abigail P. Johnson | 27.79M | 4.94% |
| 2018-02-02 | Ian Michael Laing | 20.35M | 3.62% |
| 2018-02-02 | George Edward Silvanus Robinson | 10.6M | 1.89% |
| 2018-02-02 | Nicholas John Cross | 29.04M | 5.17% |
| 2018-01-29 | M. James Barrett | 72.14M | 12.80% |
| 2018-01-29 | Forest Baskett | 72.14M | 12.80% |
| 2018-01-29 | New Enterprise Associates 14, L.P. | 72.14M | 12.80% |
| 2018-01-29 | NEA Partners 14, L.P. | 72.14M | 12.80% |
| 2018-01-29 | Peter J. Barris | 72.14M | 12.80% |
| 2018-01-29 | Anthony A. Florence, Jr. | 72.14M | 12.80% |
| 2018-01-29 | Patrick J. Kerins | 72.14M | 12.80% |
| 2018-01-29 | David M. Mott | 72.49M | 12.90% |
| 2018-01-29 | Scott D. Sandell | 72.14M | 12.80% |
| 2018-01-29 | Peter W. Sonsini | 72.14M | 12.80% |
| 2018-01-29 | Ravi Viswanathan | 72.14M | 12.80% |
| 2018-01-29 | NEA 14 GP, LTD | 72.14M | 12.80% |
| 2018-01-26 | OrbiMed Advisors LLC | 36.9M | 6.56% |
| 2018-01-26 | OrbiMed Capital GP V LLC | 36.9M | 6.56% |
| 2017-09-11 | Matrix Capital Management Company LP | 72.26M | 12.90% |
| 2017-09-11 | David E. Goel | 72.26M | 12.90% |
| 2017-02-03 | Nicholas John Cross | 29.32M | 6.90% |
| 2017-02-03 | George Edward Silvanus Robinson | 22.9M | 5.39% |
| 2017-02-03 | Ian Michael Laing | 29.35M | 6.91% |
| 2016-04-13 | Immunocore Limited | 26.98M | 6.40% |
| 2016-03-25 | Ian Michael Laing | 29.2M | 6.88% |
| 2016-03-25 | Nicholas John Cross | 29.04M | 6.84% |
| 2016-03-25 | George Edward Silvanus Robinson | 29.94M | 7.05% |
| 2016-02-10 | Patrick J. Kerins | 59.27M | 14.00% |
| 2016-02-10 | New Enterprise Associates 14, L.P. | 59.27M | 14.00% |
| 2016-02-10 | Peter J. Barris | 59.27M | 14.00% |
| 2016-02-10 | Forest Baskett | 59.27M | 14.00% |
| 2016-02-10 | David M. Mott | 59.43M | 14.00% |
| 2016-02-10 | Scott D. Sandell | 59.27M | 14.00% |
| 2016-02-10 | Ravi Viswanathan | 59.27M | 14.00% |
| 2016-02-10 | M. James Barrett | 59.27M | 14.00% |
| 2016-02-10 | Anthony A. Florence, Jr. | 59.27M | 14.00% |
| 2016-02-10 | Peter W. Sonsini | 59.27M | 14.00% |
| 2016-02-10 | Harry R. Weller | 59.27M | 14.00% |
| 2016-02-10 | NEA Partners 14, L.P. | 59.27M | 14.00% |
| 2016-02-10 | NEA 14 GP, LTD | 59.27M | 14.00% |
| 2016-02-10 | Krishna S. Kolluri | 59.27M | 14.00% |
| 2015-11-19 | OrbiMed Capital GP V LLC | 28.04M | 6.60% |
| 2015-11-19 | OrbiMed Advisors LLC | 28.04M | 6.60% |
| 2015-11-19 | Samuel D. Isaly | 28.04M | 6.60% |
| 2015-05-15 | Samuel D. Isaly | 26.47M | 6.20% |
| 2015-05-15 | OrbiMed Capital GP V LLC | 26.47M | 6.20% |
| 2015-05-15 | OrbiMed Advisors LLC | 26.47M | 6.20% |
| 2015-05-11 | FMR LLC | 24.88M | 6.02% |
| 2015-05-11 | Edward C. Johnson 3d | 24.88M | 6.02% |
| 2015-05-11 | Abigail P. Johnson | 24.88M | 6.02% |
ADAP Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.54 | 252.3M | $135.91M | $91.14M | $74.21M | $118.98M |
| 2023-12-31 | $0.79 | 201.07M | $159.45M | $143.99M | $25.24M | $40.7M |
| 2022-12-31 | $1.46 | 161.21M | $235.36M | $108.03M | $23.08M | $150.41M |
| 2021-12-31 | $3.75 | 155.81M | $584.27M | $149.95M | $25.47M | $459.79M |
| 2020-12-31 | $5.39 | 142.46M | $767.88M | $56.88M | $23.71M | $734.71M |
| 2019-12-31 | $1.20 | 104.97M | $125.96M | $50.41M | $25.46M | $101.01M |
| 2018-12-31 | $5.75 | 97.39M | $559.99M | $68.38M | $136.76M | $628.37M |
| 2017-12-31 | $6.68 | 87.94M | $587.44M | $84.04M | $124.22M | $627.61M |
| 2016-12-31 | $4.05 | 70.79M | $286.68M | $158.78M | -$ | $127.9M |
| 2015-06-30 | $18.33 | 35.78M | $655.92M | $229.06M | -$ | $426.86M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-06-30 | $0.24 | 264.09M | $63.3M | $26.06M | $48.68M | $85.92M |
| 2025-03-31 | $0.20 | 257.03M | $50.63M | $41.05M | $48.71M | $58.29M |
| 2024-12-31 | $0.54 | 255.94M | $137.88M | $91.14M | $74.21M | $120.95M |
| 2024-09-30 | $0.95 | 255.77M | $243.08M | $116.74M | $74.5M | $200.84M |
| 2024-06-30 | $1.05 | 255.59M | $268.37M | $211.81M | $47.35M | $103.91M |
| 2024-03-31 | $1.47 | 241.87M | $355.55M | $140.67M | $23.69M | $238.58M |
| 2023-12-31 | $0.79 | 227.11M | $180.1M | $143.99M | $25.24M | $61.34M |
| 2023-09-30 | $0.78 | 226.31M | $176.52M | $90.06M | $25.6M | $112.06M |
| 2023-06-30 | $0.93 | 184.69M | $170.84M | $76.97M | $26.34M | $120.22M |
| 2023-03-31 | $1.09 | 165.22M | $180.09M | $119.87M | $22.83M | $83.06M |
| 2022-12-31 | $1.46 | 164.12M | $239.61M | $108.03M | $23.08M | $154.66M |
| 2022-09-30 | $1.08 | 163.47M | $176.54M | $79M | $22.4M | $119.94M |